What is Scott Coleman email address?

Scott Coleman's primary email address is ********@xiliotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Scott Coleman work for?

Scott Coleman is a Chief Development Officer (CDO) at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.

Where Scott Coleman graduated from?

Scott Coleman holds a degree in Toxicology from North Carolina State University.

How can I directly contact Scott Coleman?

To contact Scott Coleman directly, you can use the email address ********@xiliotx.com. Complete contact information is available upon registration with Muraena.

Who is Scott Coleman?

Scott Coleman is an accomplished Chief Development Officer at Xilio Therapeutics, specializing in the pharmaceutical and medicine manufacturing industry. With a robust background in toxicology, he holds a PhD from North Carolina State University and a BS from Northeastern University. His career spans over two decades in various leadership roles, including Vice President of Nonclinical Development at Acceleron Pharma and Senior Director positions at both Merck and Cubist Pharmaceuticals. Scott is known for his strategic vision in drug development and has a proven track record of leading teams to success in preclinical safety evaluation. His experience in both large corporations and smaller biotech firms highlights his versatility in adapting to different organizational environments. Scott's commitment to innovation and excellence in the pharmaceutical field makes him a valuable asset to any organization.